AGILENT TECHNOLOGIES, INC.
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 10/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 3,354 | 33.2 |
| Stockholders' equity | 6,741 | 66.8 |
| Total capitalization | 10,095 | 100.0 |
281,928,854 shares outstanding at 26 August 2026 (cover page of the 10-Q filed 1 September 2026).
LONG-TERM DEBT 10/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 3,050 |
| Short-term borrowings / commercial paper | 304 |
CAPITAL STOCK 10/31/25
| Common shares authorized | 2,000,000,000 |
| Common shares issued | 283,054,377 |
| Par or stated value per share ($) | 0.01 |
| Preferred stock ($ millions) | 0 |
| Outstanding at 8/26/26 | 281,928,854 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | 0.99 | 21.7 |
| 2024 | 0.94 | 21.3 |
| 2023 | 0.90 | 21.5 |
| 2022 | 0.84 | 20.1 |
| 2021 | 0.78 | 19.7 |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware.
BUSINESS: Classified by the SEC under Standard Industrial Classification 3826, Laboratory Analytical Instruments. Large accelerated filer. Principal executive office: 5301 Stevens Creek Blvd, Santa Clara, CA 95051. Fiscal year ends October 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 10/31/25 | 10/31/24 | 10/31/23 |
|---|---|---|---|
| Revenues | 6,948 | 6,510 | 6,833 |
| Cost of revenues | 3,305 | 2,975 | 3,368 |
| Research and development | 455 | 479 | 481 |
| Selling, general and administrative | 1,709 | 1,568 | 1,634 |
| Depreciation and amortization | 288 | 257 | 271 |
| Operating income | 1,479 | 1,488 | 1,350 |
| Interest expense | 112 | 96 | 95 |
| Income before income taxes | 1,435 | 1,521 | 1,339 |
| Income taxes | 132 | 232 | 99 |
| Net income | 1,303 | 1,289 | 1,240 |
| Earned per share, diluted ($) | 4.57 | 4.43 | 4.19 |
| Dividends per share ($) | 0.99 | 0.94 | 0.90 |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 10/31/25 | 10/31/24 |
|---|---|---|
| Cash and equivalents | 1,789 | 1,329 |
| Receivables, net | 1,487 | 1,324 |
| Inventories | 1,025 | 972 |
| Total current assets | 4,594 | 3,959 |
| Property, plant and equipment, net | 2,023 | 1,778 |
| Goodwill | 4,473 | 4,477 |
| Total assets | 12,727 | 11,846 |
| Total current liabilities | 2,347 | 1,895 |
| Total liabilities | 5,986 | 5,948 |
| Stockholders' equity | 6,741 | 5,898 |
| Total liabilities and equity | 12,727 | 11,846 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/31/25 | 6,948 | 1,479 | 1,303 | 18.8 | 4.57 | 0.99 | 1,559 | 407 | 1,152 | 12,727 | 5,986 | 3,354 | 6,741 | 19.3 | 0.50 |
| 10/31/24 | 6,510 | 1,488 | 1,289 | 19.8 | 4.43 | 0.94 | 1,751 | 378 | 1,373 | 11,846 | 5,948 | 3,390 | 5,898 | 21.9 | 0.57 |
| 10/31/23 | 6,833 | 1,350 | 1,240 | 18.1 | 4.19 | 0.90 | 1,772 | 298 | 1,474 | 10,763 | 4,918 | 2,735 | 5,845 | 21.2 | 0.47 |
| 10/31/22 | 6,848 | 1,618 | 1,254 | 18.3 | 4.18 | 0.84 | 1,312 | 291 | 1,021 | 10,532 | 5,227 | 2,769 | 5,305 | 23.6 | 0.52 |
| 10/31/21 | 6,319 | 1,347 | 1,210 | 19.1 | 3.94 | 0.78 | 1,485 | 188 | 1,297 | 10,705 | 5,316 | 2,729 | 5,389 | 22.5 | 0.51 |
| 10/31/20 | 5,339 | 846 | 719 | 13.5 | 2.30 | 0.72 | 921 | 119 | 802 | 9,627 | 4,754 | 2,359 | 4,873 | 14.8 | 0.48 |
| 10/31/19 | 5,163 | 941 | 1,071 | 20.7 | 3.37 | 0.66 | 1,021 | 155 | 866 | 9,452 | 4,704 | 2,407 | 4,748 | 22.6 | 0.51 |
| 10/31/18 | 4,914 | 904 | 316 | 6.4 | 0.97 | 0.60 | 1,087 | 177 | 910 | 8,541 | 3,970 | 1,799 | 4,567 | 6.9 | 0.39 |
| 10/31/17 | 4,472 | 807 | 684 | 15.3 | 2.10 | 0.53 | 889 | 176 | 713 | 8,426 | 3,591 | 2,011 | 4,831 | 14.2 | 0.42 |
| 10/31/16 | 4,202 | 615 | 462 | 11.0 | 1.40 | 0.46 | 793 | 139 | 654 | 7,794 | 3,548 | 1,904 | 4,243 | 10.9 | 0.45 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
AGILENT TECHNOLOGIES, INC.
CIK 1090872 · EIN 77-0518772
PRINCIPAL OFFICE:
5301 Stevens Creek Blvd, Santa Clara, CA 95051
Tel.: (408) 345-8886
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
3826 · Laboratory Analytical Instruments
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 10/31/25, filed 22 December 2025
FORMER NAMES:
AGILENT TECHNOLOGIES INC
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 12/22/25) · 10-K FY2024 (filed 12/20/24) · 10-K FY2023 (filed 12/20/23) · 10-K FY2022 (filed 12/21/22) · 10-K FY2021 (filed 12/17/21) · 10-K FY2020 (filed 12/18/20) · 10-K FY2019 (filed 12/19/19) · 10-K FY2018 (filed 12/20/18). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.